An
ultraefficient cap-exchange protocol (UCEP) that can convert hydrophobic
quantum dots (QDs) into stable, biocompatible, and aggregation-free
water-dispersed ones at a ligand:QD molar ratio (LQMR) as low as 500,
some 20–200-fold less than most literature methods, has been
developed. The UCEP works conveniently with air-stable lipoic acid
(LA)-based ligands by exploiting tris(2-carboxylethyl phosphine)-based
rapid in situ reduction. The resulting QDs are compact (hydrodynamic
radius, Rh, < 4.5
nm) and bright (retaining > 90% of original fluorescence), resist
nonspecific adsorption of proteins, and display good stability in
biological buffers even with high salt content (e.g., 2 M NaCl). These
advantageous properties make them well suited for cellular imaging
and ratiometric biosensing applications. The QDs prepared by UCEP
using dihydrolipoic acid (DHLA)-zwitterion ligand can be readily conjugated
with octa-histidine (His8)-tagged antibody mimetic proteins
(known as Affimers). These QDs allow rapid, ratiometric detection
of the Affimer target protein down to 10 pM via a QD-sensitized Förster
resonance energy transfer (FRET) readout signal. Moreover, compact
biotinylated QDs can be readily prepared by UCEP in a facile, one-step
process. The resulting QDs have been further employed for ratiometric
detection of protein, exemplified by neutravidin, down to 5 pM, as
well as for fluorescence imaging of target cancer cells.